WOODHOUSE DAVID J
Insider CIK 1642995 · NGM Chief Executive Officer, Director · SRZN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SRZN Surrozen, Inc./DE | A Award deriv | 2026-05-13 | 2026-05-14 | 5,550 | — | $0 | 5,550 | SEC↗ |
| SRZN Surrozen, Inc./DE | A Award deriv | 2025-05-14 | 2025-05-15 | 1,333 | — | $0 | 1,333 | SEC↗ |
| SRZN Surrozen, Inc./DE | A Award deriv | 2024-06-05 | 2024-06-06 | 1,333 | — | $0 | 1,333 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 255,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 95,400 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 500,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 381,600 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 500,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 450,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 400,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 200,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 500,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 57,833 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 87,013 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | U Tender | 2024-04-05 | 2024-04-08 | 97,654 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | U Tender | 2024-04-05 | 2024-04-08 | 23,993 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | F Tax w/h | 2024-01-16 | 2024-01-18 | 13,032 | $1.34 | $17.5K | 131,822 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2023-11-06 | 2023-11-08 | 57,833 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-11-06 | 2023-11-08 | 255,000 | — | $0 | 255,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2023-11-06 | 2023-11-08 | 255,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-11-06 | 2023-11-08 | 87,013 | — | $0 | 87,013 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2023-11-06 | 2023-11-08 | 87,013 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-11-06 | 2023-11-08 | 57,833 | — | $0 | 57,833 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-11-06 | 2023-11-08 | 500,000 | — | $0 | 500,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2023-11-06 | 2023-11-08 | 500,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-11-06 | 2023-11-08 | 200,000 | — | $0 | 200,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2023-11-06 | 2023-11-08 | 200,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-11-06 | 2023-11-08 | 400,000 | — | $0 | 400,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2023-11-06 | 2023-11-08 | 400,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-11-06 | 2023-11-08 | 450,000 | — | $0 | 450,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2023-11-06 | 2023-11-08 | 450,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-11-06 | 2023-11-08 | 500,000 | — | $0 | 500,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2023-11-06 | 2023-11-08 | 500,000 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | A Award deriv | 2023-05-18 | 2023-05-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-03-02 | 2023-03-06 | 500,000 | — | $0 | 500,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-03-02 | 2023-03-06 | 381,600 | — | $0 | 381,600 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award | 2023-03-02 | 2023-03-06 | 127,200 | — | $0 | 144,854 | SEC↗ |
| SRZN Surrozen, Inc./DE | A Award deriv | 2022-06-07 | 2022-06-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2022-03-03 | 2022-03-04 | 500,000 | — | $0 | 500,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise deriv | 2021-12-29 | 2021-12-30 | 12,987 | — | $0 | 87,013 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise deriv | 2021-12-29 | 2021-12-30 | 4,667 | — | $0 | 57,833 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise | 2021-12-29 | 2021-12-30 | 4,667 | $8.14 | $38.0K | 17,654 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise | 2021-12-29 | 2021-12-30 | 12,987 | $7.70 | $100.0K | 12,987 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise deriv | 2021-11-18 | 2021-11-19 | 15,000 | — | $0 | 255,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | S Sale | 2021-11-18 | 2021-11-19 | 15,000 | $20.02 | $300.3K | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | M Exercise | 2021-11-18 | 2021-11-19 | 15,000 | $7.54 | $113.1K | 15,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2021-03-17 | 2021-03-18 | 450,000 | — | $0 | 450,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2020-02-04 | 2020-02-06 | 400,000 | — | $0 | 400,000 | SEC↗ |